Pfizer To Partner With Indian Firms To Research, Develop Cancer Drugs
This article was originally published in PharmAsia News
Pfizer Inc. is said to be considering partnerships with Indian drug makers to research and develop cancer drugs as part of its concentration on treatments for emerging markets.
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.